Recombinant Yersinia pestis bv. Antiqua GMP synthase [glutamine-hydrolyzing] (guaA), partial

What is the biological role of GMP synthase (guaA) in Yersinia pestis metabolism?

GMP synthase catalyzes the amination of xanthosine 5'-monophosphate (XMP) to guanosine 5'-monophosphate (GMP), representing a critical step in guanine nucleotide biosynthesis. This enzyme requires both ATP and glutamine as substrates, employing a dual catalytic mechanism where glutamine hydrolysis provides the ammonia group for XMP amination . Within Y. pestis, guaA functions as part of the guaBA operon, where guaB encodes IMP dehydrogenase that catalyzes the preceding step (IMP to XMP conversion). Together, these enzymes form a sequential pathway essential for de novo purine biosynthesis. When the guaBA operon is deleted or disrupted, Y. pestis becomes auxotrophic for guanine, demonstrating the critical nature of this biosynthetic pathway .

What expression systems yield optimal results for recombinant Y. pestis guaA production?

Escherichia coli expression systems have proven most effective for recombinant Y. pestis protein production, including guaA. The research literature demonstrates successful expression using E. coli with N-terminal histidine tags to facilitate purification . For optimal expression, consider the following methodological parameters:

The expressed protein typically requires purification via immobilized metal affinity chromatography (IMAC) using the histidine tag, followed potentially by size exclusion chromatography for higher purity applications .

What structural features characterize Y. pestis GMP synthase and how do they compare with orthologs?

Y. pestis GMP synthase maintains the conserved two-domain architecture typical of bacterial GMP synthases: an N-terminal glutamine amidotransferase (GAT) domain and a C-terminal synthase domain. The enzyme functions as a homodimer with the active sites formed at the interface between domains. While the search results don't provide specific structural data for Y. pestis GMP synthase, comparative analysis with other bacterial GMP synthases reveals several conserved features:

• The N-terminal domain contains a catalytic triad (Cys-His-Glu) that hydrolyzes glutamine to glutamate and ammonia

• The C-terminal domain binds XMP and ATP, facilitating the amination reaction

• A flexible linker region connects the two domains, allowing conformational changes during catalysis

• Conserved binding pockets for substrate recognition and catalysis

Protein sequence analysis would likely reveal >70% sequence identity with GMP synthases from other Enterobacteriaceae, but potentially significant differences from the human ortholog that could be exploited for selective inhibition .

How does temperature affect the activity and regulation of Y. pestis guaA?

Temperature-dependent regulation is particularly relevant for Y. pestis, which transitions between different host environments: the flea vector (approximately 26°C) and the mammalian host (37°C). Transcriptional profiling has revealed that guaBA expression is repressed when Y. pestis is shifted from 26°C to 37°C in vitro . This temperature-dependent regulation suggests adaptation to different metabolic requirements or purine availability in these distinct environments.

The relationship between temperature and guaA expression likely influences several aspects of Y. pestis pathophysiology:

• Differential metabolic requirements between arthropod and mammalian hosts

• Coordination of purine biosynthesis with temperature-dependent virulence factor expression

• Potential energy conservation mechanisms during host transition

Researchers should consider these temperature effects when designing experimental protocols, particularly for enzyme activity assays and expression studies.

How does disruption of guaA affect Y. pestis virulence in animal models?

Deletion of the guaBA operon in Y. pestis creates a highly attenuated strain with significantly reduced virulence in mouse models of infection. Even at doses as high as 7×10⁴ CFU, guaBA mutants were not lethal by either subcutaneous or intravenous routes of infection . This represents an attenuation of at least 10,000-fold compared to wild-type Y. pestis, which has a minimum lethal dose (MLD) of 1 CFU when administered subcutaneously .

The virulence attenuation of guaBA mutants appears more pronounced than that observed with other biosynthetic pathway mutations. For example, an aroA mutant of the same Y. pestis strain retained some virulence in mice . This suggests that guanine nucleotide biosynthesis is particularly critical for Y. pestis survival and replication in the host environment.

What mechanisms explain the attenuation of Y. pestis guaA mutants in vivo?

The marked attenuation of Y. pestis guaBA mutants likely results from multiple factors:

• Insufficient purine availability in host tissues to support bacterial growth and replication

• Inability to synthesize guanine nucleotides impairs critical cellular functions including DNA replication, RNA synthesis, and signal transduction

• Reduced expression of virulence factors that might depend on guanine nucleotide availability

• Compromised bacterial stress responses that require GTP-dependent signaling

Studies with other purine auxotrophs have demonstrated they are unable to grow in macrophages , suggesting limited purine availability in the intracellular environment where Y. pestis must replicate during infection. This finding indicates that mammals carefully regulate purine pools within cells as a form of nutritional immunity, restricting pathogen access to these essential metabolites.

What evidence supports the use of Y. pestis guaA mutants as live attenuated vaccine candidates?

Y. pestis guaBA mutants have demonstrated promising characteristics as potential live attenuated vaccine candidates. Key evidence supporting their development includes:

• High level of attenuation: The guaBA mutation renders Y. pestis highly attenuated in vivo, with no observed lethality even at doses of 7×10⁴ CFU .

• Protective immunity: Mice vaccinated with a single dose of 7×10⁴ CFU via the intravenous route were fully protected against subsequent lethal challenge with the Y. pestis parental strain .

• Antibody responses: Vaccination induces F1 and V antigen-specific serum IgG antibodies, which have been associated with protection against Y. pestis infection .

• Safety profile: The guaBA deletion creates a defined genetic lesion that is unlikely to revert to virulence, addressing safety concerns associated with live attenuated vaccines.

The table below summarizes the protective efficacy observed in mice immunized with the Y. pestis guaBA mutant:

*Exact survival percentages not specified in the search results

How do immune responses to Y. pestis guaA mutants compare with other vaccination approaches?

Vaccination with Y. pestis guaBA mutants induces protective immunity characterized by F1 and V antigen-specific antibody responses. The highest antibody titers were observed in mice immunized intravenously with the undiluted culture (7×10⁴ CFU), with F1-specific titers increasing in a dose-dependent manner . This approach offers several advantages over other plague vaccine strategies:

• Compared to subunit vaccines based on F1 and V antigens alone, live attenuated vaccines like the guaBA mutant present the full complement of Y. pestis antigens in their native conformation.

• Unlike killed whole-cell vaccines, which have shown limited efficacy against pneumonic plague, live attenuated strains can stimulate both humoral and cell-mediated immunity.

• The guaBA mutant appears to offer superior protection compared to other attenuated strains such as aroA mutants, which retained some virulence in mice .

• Unlike empirically derived attenuated strains with undefined genetic lesions, the defined nature of the guaBA mutation allows for precise characterization and quality control.

What enzymatic parameters distinguish Y. pestis GMP synthase from the human ortholog?

Understanding the biochemical differences between bacterial and human GMP synthases is essential for developing selective inhibitors with therapeutic potential. While specific kinetic parameters for Y. pestis GMP synthase are not directly provided in the search results, studies with GMP synthases from other pathogens reveal several distinguishing features that may apply to Y. pestis:

• Binding cooperativity: GMP synthases from pathogens like Cryptococcus neoformans show differences in binding cooperativity compared to the human ortholog . These differences could potentially be exploited for selective inhibition.

• Dual catalytic mechanism: The conversion of XMP to GMP requires the coordinated action of the glutamine amidotransferase domain, which produces ammonia, and the synthase domain, which uses the ammonia to aminate XMP .

• Substrate affinity: Differences in Km values for ATP, XMP, or glutamine between bacterial and human enzymes could provide a basis for selective inhibition.

• Inhibitor sensitivity: Bacterial GMP synthases may exhibit differential sensitivity to competitive and allosteric inhibitors compared to their human counterparts.

Detailed steady-state kinetic analysis of recombinant Y. pestis GMP synthase would be necessary to fully characterize these differences and exploit them for therapeutic development.

What methodological approaches are optimal for measuring Y. pestis GMP synthase activity?

Several complementary approaches can be employed to measure the activity of Y. pestis GMP synthase, each with specific advantages:

For comprehensive characterization, a combination of these methods should be employed. Initial screening can utilize spectrophotometric or coupled assays, while detailed kinetic studies and inhibitor evaluation may require the higher sensitivity of radiometric or mass spectrometry approaches.

What genetic approaches have proven effective for manipulating the Y. pestis guaBA operon?

Genetic manipulation of the Y. pestis guaBA operon has been successfully accomplished using allelic replacement techniques. The methodology involves:

• PCR amplification of DNA segments flanking the target region of the guaBA operon

• Introduction of a selectable marker (typically a kanamycin-resistance cassette) between these flanking segments

• Cloning into a suicide vector that confers sucrose sensitivity (such as pDM4)

• Selection for double recombination events that replace the native operon with the mutant construct

A specific example from the literature employed the following approach:

• Two DNA segments of the Y. pestis guaBA operon were amplified using PCR

• An overlapping PCR was performed to create a fragment complementary to the 5' end (codons 1-140) of the guaB gene and the 3' end (codons 394-525) of the guaA gene, but lacking codons 141-347 of guaB, the intergenic region, and codons 1-393 of guaA

• A SpeI restriction site was introduced at the junction between the two fused PCR products

• The fragment was cloned into suicide vector pDM4

• A kanamycin-resistance cassette was introduced into the SpeI site

• The resulting construct was used for allelic replacement in Y. pestis

This approach creates defined deletions with minimal polar effects, allowing for precise genetic analysis of guaBA function.

How can researchers effectively analyze the transcriptional regulation of guaA in response to environmental conditions?

Understanding the transcriptional regulation of guaA in Y. pestis requires multiple complementary approaches:

• Quantitative RT-PCR: This remains the gold standard for measuring transcript levels across different environmental conditions. Primers should be designed to specifically amplify guaA transcripts, with normalization to suitable reference genes that maintain stable expression across the conditions being tested.

• Transcriptional reporter fusions: Creating fusions of the guaBA promoter region to reporter genes (such as lacZ, gfp, or luciferase) allows for real-time monitoring of transcriptional activity in various conditions.

• RNA-seq: This approach provides a global view of the transcriptome, allowing researchers to identify co-regulated genes and potentially uncover regulatory networks controlling guaBA expression.

• Chromatin immunoprecipitation (ChIP): If specific transcriptional regulators are suspected to control guaBA expression, ChIP can identify their binding sites in the promoter region.

• In vitro transcription assays: Using purified RNA polymerase and potential regulatory factors to assess transcription from the guaBA promoter in a controlled environment.

Transcriptional profiling has already revealed that guaBA expression is repressed when Y. pestis is shifted from 26°C to 37°C in vitro , suggesting temperature-dependent regulation that could be explored further using these techniques.

How conserved is GMP synthase (guaA) across Yersinia species and other bacterial pathogens?

GMP synthase is highly conserved across bacterial species, reflecting its essential role in purine metabolism. In Yersinia species, guaA is likely maintained with high sequence conservation, though with potential adaptations specific to each species' ecological niche and pathogenic lifestyle. Comparative genomic analysis would reveal:

• Core conserved domains required for catalytic function

• Species-specific variations that may reflect adaptation to different host environments

• Conservation of the operon structure and regulatory elements

The guaBA operon structure, with guaB and guaA as adjacent genes governed by a single promoter upstream of guaB, is maintained across many Enterobacteriaceae . This conservation extends to other bacterial pathogens where guaA mutations have been shown to attenuate virulence, including Salmonella species, Shigella flexneri, and Francisella tularensis .

What evolutionary insights can be gained from comparing Y. pestis guaA with orthologs in other organisms?

Evolutionary analysis of Y. pestis guaA can reveal important insights about bacterial adaptation and pathogen evolution:

• Selective pressure analysis can identify residues under positive or purifying selection, highlighting functionally critical regions of the enzyme.

• Comparison with GMP synthases from evolutionarily distant organisms can reveal ancient conserved features essential for catalysis versus more recently evolved adaptations.

• Analysis of guaA sequences across the evolutionary history of Yersinia (from Y. pseudotuberculosis to modern Y. pestis) could reveal adaptive changes associated with the evolution of plague pathogenesis.

• Comparing bacterial and eukaryotic GMP synthases can identify divergent features that might be exploited for selective inhibitor development.

These evolutionary insights have practical applications in understanding Y. pestis pathogenesis and developing targeted therapeutics that exploit bacterial-specific features of GMP synthase.

What are the most promising approaches for developing selective inhibitors of Y. pestis GMP synthase?

Development of selective inhibitors targeting Y. pestis GMP synthase represents a promising avenue for novel therapeutics. Several methodological approaches warrant investigation:

• Structure-guided design: Determining the crystal structure of Y. pestis GMP synthase would enable rational design of inhibitors that exploit structural differences from the human enzyme.

• Fragment-based screening: Identifying small molecular fragments that bind to specific pockets in the enzyme structure, followed by optimization to improve potency and selectivity.

• Exploiting allosteric sites: Targeting regulatory sites unique to the bacterial enzyme rather than the highly conserved active site may provide greater selectivity.

• Natural product screening: Many existing nucleotide synthesis inhibitors are derived from natural products, suggesting this remains a fertile source for novel lead compounds.

• Prodrug approaches: Designing compounds that are selectively activated by bacterial metabolism or enzymes to improve targeting to Y. pestis.

The dual domain nature of GMP synthase offers multiple targetable sites, including the glutamine binding pocket, the ATP binding site, the XMP binding site, and the interdomain channel that transfers ammonia between active sites.

How can systems biology approaches enhance our understanding of guaA function in Y. pestis pathogenesis?

Systems biology approaches offer powerful tools for understanding the role of guaA in Y. pestis pathogenesis within the broader context of bacterial metabolism and host-pathogen interactions:

• Metabolomics analysis comparing wild-type and guaA mutant strains can reveal:

  • Changes in nucleotide pool compositions

  • Unexpected metabolic adaptations to guanine auxotrophy

  • Metabolic bottlenecks that might be exploited therapeutically

• Proteomics studies can identify:

  • Changes in protein expression profiles resulting from guaA mutation

  • Potential protein-protein interactions involving GMP synthase

  • Post-translational modifications that might regulate enzyme activity

• Computational modeling of purine metabolism can:

  • Predict metabolic flux changes under different environmental conditions

  • Identify additional targets that might synergize with guaA inhibition

  • Simulate the effects of different inhibitory strategies

• Host-pathogen interaction studies can determine:

  • How host cells regulate purine availability as a defense mechanism

  • Whether guaA is differentially expressed in different host cell types

  • If host factors directly interact with bacterial GMP synthase

These multidisciplinary approaches would provide a comprehensive understanding of guaA's role in Y. pestis pathogenesis beyond its enzymatic function.